AQB
AQB
NASDAQ · Biotechnology

Aquabounty Technologies

$0.92
+0.05 (+6.23%)
As of Mar 31, 5:01 PM ET ·
Financial Highlights (FY 2026)
Revenue
2.52M
Net Income
-151,194,676
Gross Margin
-518.0%
Profit Margin
-1,132.4%
Rev Growth
+166.9%
D/E Ratio
0.21
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -518.0% 56.6% 56.6% 56.6%
Operating Margin -566.2% 16.8% 16.3% 16.4%
Profit Margin -1,132.4% 13.8% 16.5% 14.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.52M 557.3K 516.3K 473.8K
Gross Profit -13,064,801 315.4K 292.2K 268.1K
Operating Income -14,279,679 93.8K 84.3K 77.8K
Net Income -151,194,676 76.7K 85.4K 67.5K
Gross Margin -518.0% 56.6% 56.6% 56.6%
Operating Margin -566.2% 16.8% 16.3% 16.4%
Profit Margin -1,132.4% 13.8% 16.5% 14.2%
Rev Growth +166.9% +2.4% +15.9% +18.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 300.9K 1.31M 1.47M 1.37M
Total Equity 1.46M 2.49M 2.28M 2.29M
D/E Ratio 0.21 0.52 0.64 0.60
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -114,761,619 122.1K 108.8K 88.6K
Free Cash Flow 55.8K 59.0K 42.6K